Apellis pharmaceuticals inc

Major-Pharmaceuticals

APLS


6400 Westwind Way
Crestwood , KY 40014

Executive/
Director

Price

  • Last Close
  • $ 33.47
    $ +0.31 0.93 %
    Jan 3, 2025
  • 52-Week High/Low
  • $72.47 - $33.64
  • YTD
  • 4.8%

  • Trading Volume
  • 49,668
  • Market Cap Full
  • $ 4B
  • Shares Outstanding
  • 118.5M
    Oct 24, 2023
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Q1 - - 1.9% 47.8% -5% -25% 7.5% 27.6% -1.9% 4.8%
Q2 - - 7.7% 28.6% 4% 47.3% -11% 38.1% -30.4% -
Q3 - - -15.5% -3.5% 8% -47.9% 51% -58.2% -2.4% -
Q4 - 54.7% -24.5% 25.3% 90.4% 43.5% -24.3% 61.2% 12.4% -
J F M A M J J A S O N D
2025 4.8% - - - - - - - - - - -
2024 5.7% -2.1% -5.2% -19.1% -17.4% 5.8% -4.6% -2.4% - - - -6%
    2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
    0%0%0%-39%130%88%-17%9%16%-47%5%

Earnings

2016 2017 2018 2019 2020 2021 2022 2023
Q1 - - -0.43 -0.87 -2.29 -2.32 -1.42 -1.56
Q2 - - -0.61 -1.12 -1.57 -2.72 -1.46 -1.02
Q3 - - -0.64 -1.1 -1.79 -2.28 -1.75 -1.17
Q4 - 0.60 -0.66 -1.81 1.06 -1.52 -1.52 -
A 0 0.6 -2.3 -4.9 -4.6 -8.8 -6.2 -3.75

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 56.3 75.3 80.4 97.7 111.3
Jun 55.9 63.2 75.5 80.5 106.5 116.5
Sep 56.2 63.7 75.6 87 109.9 117.7
Dec 56.2 63.9 75.7 87.3 110.6 118.5

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover 0.1 5 - - -
Fixed Asset Turnover 3.4 1.8 9.7 - -
Total Asset Turnover 0.1 0.1 0.3 - -
Leverage
Debt Ratio - - 0.4 0.4 0.1
Debt – Equity Ratio - - 1.8 4.2 0.2
Interest Coverage -10.4 -2.6 -1.6 -16.9 -
Equity multiplier 0.1 0.2 0.1 0.1 -